Stock Ratings / Health Care / OPCH / earnings

LFST (67) HIMS (60) CHE (83) AVAH (65) ⌘ Pro Terminal →

Option Care Health Inc. (OPCH) Next Earnings Date & Expected ±1.8% Move

$31.83 -0.06% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $31.90

Option Care Health Inc. (OPCH) earns a Roarable Rating of B (Buy) with 74/100 RQD Confidence. High-quality cash engine (19% profit margin, 12% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

📊 Historical Track Record: Scores of 74/100 (B) historically ranked in the Top 12% of excess returns over the next 90 days (+7.3% avg 90D alpha vs SPY • 69.4% hit rate) →

ROARABLE B • BUY Cap $4.77B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on OPCH Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is OPCH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Option Care Health Inc. (NASDAQ: OPCH) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 74/100 at a spot price of $31.83 (-0.06% 1D, market cap $4.77B). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 16/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 15/20. Across 1016 tracked Health Care issuers, OPCH ranks #40 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does OPCH compare to LFST and HIMS in the Health Care sector?

▼

Within the Health Care sector (Medical/Nursing Services), OPCH carries a Roarable B (74/100 RQD), trailing P/E of 23.0x, gross margin of 19.3%, and ROIC of 11.9%. By comparison, LFST (LifeStance Health Group Inc.) holds a C+ grade (67/100 RQD, P/E N/A, ROIC 1.2%, cap $5.12B) and HIMS (Hims & Hers Health Inc.) posts a C- grade (60/100 RQD, P/E 53.9x, ROIC 8.4%, cap $6.46B). Among the 5-stock peer group, OPCH leads on earnings multiple (23.0x) while CHE leads on capital efficiency (23.4% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for OPCH?

▼

Per OPCH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001014739), Option Care Health Inc. generated $5.65B in revenue (+13.0% YoY), $207.6M in net income, and $217.1M in free cash flow against $3.46B in total assets and $1.15B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $31.90 (+0.23%)🧬 Cannibal Buyback (-2.08% YoY Shares)⚙️ Cash Engine: 14/20 (B-) • 3.8% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 74/100 (B) historically ranked in the Top 12% of excess returns over the next 90 days (+7.3% avg 90D alpha vs SPY • 69.4% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERBUY • B

3-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B · Rk B

Each axis scored 0–20

12M PRICE TARGET CONE+7.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for OPCH)Realized 20D OHLCV Swing Band: ±1.8%

Deterministic 5-Pillar Attribution (74/100 Composite)

🔍 WHY OPCH SCORES 74/100 (B) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+16/20 pts (22% of score)

20D Institutional Volume Accumulation (±1.8% realized swing band)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+16/20 pts (22% of score)

Altman Z-Score 3.81 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▼ #1 Drag / Risk Factor: Macro Regime Fit13/20 pts (-7 pt drag)

Macro rate sensitivity & RSI-14 (83.8) create a -7 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade B-$31.12+0.5% Next Q

Q2 (-2Q)

Grade B-$31.29+0% Next Q

Q3 (-1Q)

Grade B$31.29+1.7% Next Q

Current

Grade B$31.83+7.3% Hist 90D α

Trajectory: B- (66) → B (74)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the OPCH Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 74/100 (B) score, OPCH faces multiple-compression risk if 23.0x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) — any gross margin slip below 16.8% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($27.00) or 200D SMA ($26.26) invalidates the momentum regime and cuts Target Base ($34.12) toward Bear Floor ($26.10).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $OPCH• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “OPCH Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 74%NO 26%Trade / Inspect Odds →

NEXT EST. WINDOW: Dec 30, 2026 (~57 DAYS)

Historical OHLCV Volatility ±1.8% Swing Band

±$0.57 Expected Swing

MODEL EARNINGS SETUP GAUGE

OPCH Quantitative Pre-Earnings Setup: 74/100

Trailing EPS: $1.39 • YoY Revenue Growth: 13%

Model Bullish Setup (74/100)Model Risk Weight (26/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
FY 2025	2025-12-31	$5.65B	$207.6M	$217.1M	19.3%
FY 2024	2024-12-31	$5.00B	$211.8M	$287.8M	20.3%
FY 2023	2023-12-31	$4.30B	$267.1M	$177.7M	19.3%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating OPCH & AI Leaders Without Chasing Tops

✓Institutional whale strikes & implied earnings move audit on OPCH
✓How disciplined traders manage risk using pre-published trigger & invalidation levels
✓Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

OPCH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +50.57%⚡ TESTING RESISTANCE

2026-11-03O $31.85H $31.85L $31.83C $31.83VOL 4.23M

RES: $32.34SUP: $23.02SMA50: $27.00SMA200: $26.26

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

OPCH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 OPCH Butterfly Map → + Track OPCH →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

16.8%/yr Implied 5Y Growth

vs. +13.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on OPCH today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for OPCH. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for OPCH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (OPCH)

Health Care Rank #40 of 1016 ⚔️ LFST vs OPCH Full Matrix →

1. Head-to-Head Health Care Peer Comparison (OPCH vs. LFST, HIMS, CHE, AVAH)

Industry: Medical/Nursing Services (29 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Option Care Health Inc. (OPCH) ranks #40 by composite RQD confidence (74/100, grade B) and #167 by equity capitalization ($4.77B). Within this direct 5-issuer industry benchmark cohort, OPCH leads on earnings valuation at 23.0x trailing P/E, while CHE leads on capital efficiency and profitability with 23.4% ROIC and 32.5% gross margin. CHE currently holds the highest overall quantitative score in the immediate peer group at 83/100 (A-) compared with OPCH at 74/100 (B).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
OPCH ACTIVE Option Care Health Inc.	B	74/100	23.0x	19.3%	11.9%	-0.06%	$4.77B	Benchmark Subject
LFST LifeStance Health Group Inc.	C+	67/100	—	—	1.2%	-1.72%	$5.12B	/lfst-vs-opch →
HIMS Hims & Hers Health Inc.	C-	60/100	53.9x	73.8%	8.4%	-6.71%	$6.46B	/hims-vs-opch →
CHE Chemed Corp	A-	83/100	—	32.5%	23.4%	-1.33%	$6.96B	/che-vs-opch →
AVAH Aveanna Healthcare Holdings Inc.	C	65/100	—	33.3%	15.7%	-0.75%	$2.87B	/avah-vs-opch →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001014739

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Option Care Health Inc. (OPCH) reported GAAP revenue of $5.65B (+13.0% vs. FY2024 revenue of $5.00B , and +31.3% cumulative change since FY2023) , GAAP net income of $207.6M, operating cash flow of $258.4M, and free cash flow of $217.1M (-24.5% YoY). On the balance sheet, OPCH closed FY2025 with $3.46B in total assets against $1.15B in total debt (Altman Z-Score: 3.81, Piotroski F-Score: 7/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$5.65B	$207.6M	$258.4M	$217.1M	$3.46B	$1.15B
FY2024 (FY)	2024-12-31	$5.00B	$211.8M	$323.4M	$287.8M	$3.42B	$1.10B
FY2023 (FY)	2023-12-31	$4.30B	$267.1M	$371.3M	$177.7M	$5.16B	$1.21B

3. OPCH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is OPCH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does OPCH compare to LFST and HIMS in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for OPCH?

Where is OPCH trading relative to its 50-day, 200-day, and 52-week technical levels?

OPCH last traded at $31.83 (-0.06% on volume of 4,228,346 shares), positioning the stock +17.89% above its 50-day simple moving average ($27.00) and +21.21% above its 200-day simple moving average ($26.26). Across its 52-week range of $18.01 to $36.80, OPCH sits at the 73.5% percentile with a 14-day RSI of 83.8 (OVERBOUGHT (>70)) and an implied next-earnings move of ±1.8% ($31.26 to $32.40).

OPCH Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is OPCH's next earnings date?

Based on SEC filing cadence, Option Care Health Inc. (OPCH)'s next quarterly reporting window is estimated around Dec 30, 2026.

How much is OPCH stock expected to move on earnings?

Volatility modeling currently projects a ±1.8% event move for OPCH, spanning a range between $31.26 and $32.4.

Direct Sub-Reports: OPCH RQD Cockpit OPCH 12M Forecast OPCH Earnings & Move OPCH Dividends & DRIP OPCH Insiders & 13F OPCH Whale Options OPCH Profit Sankey OPCH News & Why

ROARABLE RATING BRIEF • RQD 74/100 (B) ✓ STAGE-C NUMBER FIREWALL VERIFIED

OPCH — Option Care Health Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:21:08Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, OPCH scores 75 out of 100, a letter grade of B, with the verdict label "Roarable Buy — Good Risk/Reward." The five pillars are:

Fundamental Cash Engine: 14 / 20. Per the RQD pillar detail, this reflects ROIC of 11.9% and an FCF yield of 4.55%. For an investor, this indicates the business earns a return above its cost of capital on the figures provided, but cash generation is moderate relative to the share price.
Whale 13F Flow: 17 / 20. The pillar is labeled as reflecting institutional accumulation and options positioning. Per the holders section, no underlying 13F detail is supplied, so the strength of this score cannot be traced to specific holders in the source data.
Insider Conviction: 15 / 20. Labeled as SEC Form 4 and Congressional PTR cluster flow. No transaction-level insider data is provided in the source data, so the basis for this score cannot be independently verified.
Macro Regime Fit: 13 / 20. Per the RQD pillar, this reflects a beta of 1.1 and sector sensitivity. For an investor, a beta slightly above 1.0 suggests the stock has tended to move modestly more than the broad market, which may amplify both gains and losses in a market swing.
Forensic Balance Sheet: 16 / 20. Per the RQD pillar, this reflects an Altman Z-Score of 3.81, a Piotroski F-Score of 7/9, and Debt/Equity of 0.87. These are the strongest individual metrics in the rating and support the view that financial distress risk appears contained on the data provided.

Upside drivers implied by the rating are the balance-sheet strength and institutional-flow signals. Valuation tradeoffs are visible in the market data: trailing P/E of 23 versus forward P/E of 19.3 implies expected earnings improvement in the source data's framing, while EV/EBITDA of 15.3 is not compared against any peer benchmark in the sources. The rating does not constitute personalized financial advice.

Snapshot

Price	Market Cap	P/E (TTM)	Forward P/E	EV/EBITDA	EPS (TTM)	Dividend Yield	Beta	52-Wk Range	ROIC %
$31.85	$4.77B	23	19.3	15.3	1.39	0%	1.1	$18.01 - $36.8	11.9%

Financial Trend

Period	Revenue	Operating Income	Net Income	EPS	FCF	Cash	Debt
FY 2025	$5649.5M	$337.9M	$207.6M	N/A	$217.1M	$232.6M	$1154.1M
FY 2024	$4998.2M	$321.8M	$211.8M	N/A	$287.8M	$412.6M	$1104.6M
FY 2023	$4302.3M	$314.6M	$267.1M	N/A	$177.7M	N/A	$1208.1M

Per the market data, gross margin is 19.3%, operating margin 6%, and net margin 3.7%, with ROIC of 11.9%. Revenue rose from $4302.3M in FY 2023 to $5649.5M in FY 2025 per the SEC financials, while net income declined from $267.1M to $207.6M over the same span. Per the RQD forensic pillar, the Altman Z-Score is 3.81, the Piotroski F-Score is 7/9, and Debt/Equity is 0.87, which the rating treats as a supportive balance-sheet posture. Filing-level EPS for each period is listed as N/A in the source data.

Open Questions

What are the terms, value, and status of the reported takeover bid referenced by Barron's, and is it confirmed?
What is the McKesson deal referenced by Citizens' downgrade, and how does it affect OPCH's revenue and margins?
What are the underlying 13F holder positions and Form 4 / Congressional PTR transactions behind the whale and insider pillar scores?
Why are EPS figures N/A in the financial filings, and what is the reported per-share profit by period?
What are the company's peer valuation benchmarks for P/E and EV/EBITDA?

OPCH Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Option Care Health Inc. (OPCH) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to OPCH Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo Finance • 19h ago

Why Option Care Health (OPCH) Stock Is Trading Up Today

Yahoo Finance report covering Option Care Health Inc. (OPCH) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE The Motley Fool • 22h ago

Why Option Care Health Stock Skyrocketed on Tuesday

The Motley Fool report covering Option Care Health Inc. (OPCH) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Barron's • 1d ago

Report of Possible $5 Billion Takeover Bid Sends Option Care Health Stock Surging

Barron's report covering Option Care Health Inc. (OPCH) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST ChartMill • 1d ago

Option Care Health (NASDAQ:OPCH): A Quality Investing Stock With Durable Growth and Strong Cash Generation

ChartMill report covering Option Care Health Inc. (OPCH) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Trefis • 1d ago

A 7-Day Winning Streak Has Option Care Health Stock Up 38%

Trefis report covering Option Care Health Inc. (OPCH) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH Investing.com • 1d ago

Citizens downgrades Option Care Health stock rating on McKesson deal

Investing.com report covering Option Care Health Inc. (OPCH) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

Option Care Health Agrees to $5.8 Billion Acquisition by CD&R and McKesson at $32.05 Per Share

Yahoo Finance report covering Option Care Health Inc. (OPCH) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Yahoo Finance • 1d ago

Option Care Health surges 22% on report of $5 billion takeover by McKesson, CD&R

Yahoo Finance report covering Option Care Health Inc. (OPCH) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

OPCH Bull vs. Bear Conversation Board — What's Your Call at $31.83?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON OPCH 🐻 33% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk 🐂 BULLISH 🎯 Target: $37.58 (+18.0%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is OPCH (B • RQD 75/100) a Buy at $31.85?

Welcome to the OPCH (Option Care Health Inc.) Roar Pit. Current RQD Composite is 75/100 (Roarable Buy — Good Risk/Reward) in Medical/Nursing Services. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

MU MultipleCompression Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $25.80 (-19.0%)

Spot @ $31.85

Pump the brakes on OPCH — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on OPCH, but look at what you are paying: 23.0x trailing P/E with 19.3% gross margins. Unless Option Care Health Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

DE DeltaGamma_99 Verified K Arena Trader 🐂 BULLISH 🎯 Target: $37.26 (+17.0%)

Spot @ $31.85

OPCH cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on OPCH, the market is fixating on short-term headline noise in Medical/Nursing Services and ignoring the balance sheet and cash flow trajectory. At $31.85 (52-wk range $18.01 - $36.80), any beat on forward guidance forces shorts and underweight funds to chase.